Published in
Springer, Cellular Oncology, 2(38), p. 119-129, 2015
DOI: 10.1007/s13402-015-0218-8
Links
- ORCID
- ORCID
- Springer | PDF
- ORCID
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
Journal article published in 2015 by
Kristy J. Gotink,
Maria Rovithi,
Richard R. de Haas,
Richard J. Honeywell 
,
Henk Dekker ,
Dennis Poel,
Kaamar Azijli,
Godefridus J. Peters,
Henk J. Broxterman,
Henk M. W. Verheul
,
Henk Dekker ,
Dennis Poel,
Kaamar Azijli,
Godefridus J. Peters,
Henk J. Broxterman,
Henk M. W. Verheul
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 